| Comparator companies |
Accord Healthcare (cisplatin, carboplatin, docetaxel, gemcitabine, paclitaxel) (CAU not returned, not participating) |
| |
Allergan (docetaxel, gemcitabine, paclitaxel, pemetrexed, vinorelbine) (CAU not returned, not participating) |
| |
Celgene (paclitaxel) (CAU not returned, not participating) |
| |
Dr Reddy’s Laboratories (docetaxel) (CAU not returned, not participating) |
| |
Hospira UK (cisplatin, carboplatin, docetaxel, gemcitabine, paclitaxel) (CAU not returned, not participating) |
| |
Lilly UK (gemcitabine, pemetrexed) (CAU not returned, not participating) |
| |
Medac GmbH (docetaxel, gemcitabine, paclitaxel, vinorelbine) (CAU not returned, not participating) |
| |
Peckforton Pharmaceuticals (paclitaxel) (CAU not returned, not participating) |
| |
Pierre Fabre (vinorelbine) (CAU not returned, not participating) |
| |
Sun Pharma (carboplatin, gemcitabine) (CAU not returned, not participating) |
| |
Sandoz (cisplatin) (CAU not returned, not participating) |
| |
Sanofi (docetaxel) (CAU not returned, not participating) |
| |
Seacross pharmaceuticals (docetaxel) (CAU not returned, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |